Trial NCT04649021
Publication Hui AH, SSRN, 2022
Dates: 2020-12-05 to 2021-01-09
Funding: Private (BioNTech ; Shanghai Fosun Pharmaceutical Development Inc.)
Conflict of interest: Yes